bromopride

Also known as 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide, Bromoprid, Bromoprida, Bromopridum

Bromopride (INN) is a dopamine antagonist with prokinetic properties widely used as an antiemetic, closely related to metoclopramide. It is not available in the United States.

Research

78 papers

Bromopride stimulates 5-HT(4)-serotonin receptors in the human atrium.Naunyn-Schmiedeberg's archives of pharmacology · 2025
Population pharmacokinetics of orally administrated bromopride: Focus on the absorption process.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2020
Bromopride, metoclopramide, or ondansetron for the treatment of vomiting in the pediatric emergency department: a randomized controlled trial.Jornal de pediatria · 2018
Development of novel montmorillonite-based sustained release system for oral bromopride delivery.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2022
Differential effects of bromopride and domperidone on cholinesterase activity in rat tissues.Life sciences · 1995

via PubMed

Wikidata facts

Mass: 343.089539

Show 5 more facts

chemical formula: C₁₄H₂₂BrN₃O₂
MCN code: 2924.29.51
canonical SMILES: CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Br
Commons category: Bromopride
defined daily dose: 20

Sources (5)

via Wikidata · CC0

~1 min read

Article

5 sections

Contents

Indications
Adverse effects
Chemistry
Availability
References

Bromopride (INN) is a dopamine antagonist with prokinetic properties widely used as an antiemetic, closely related to metoclopramide. It is not available in the United States.

Bromopride appears to be safe and effective for use in pregnancy.